Tower Research Capital LLC (Trc) Assertio Holdings, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,429 shares of ASRT stock, worth $3,498. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,429
Previous 6,000
26.18%
Holding current value
$3,498
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ASRT
# of Institutions
82Shares Held
26.9MCall Options Held
447KPut Options Held
76.3K-
Nantahala Capital Management, LLC New Canaan, CT8.81MShares$6.96 Million0.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$3.5 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.94MShares$2.32 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.39MShares$1.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.02MShares$807,5900.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $38.1M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...